Related Experiment Video
Updated: May 28, 2026

Barnes Maze Testing Strategies with Small and Large Rodent Models
Published on: February 26, 2014
Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome
Wei Wang1, Jinyou Li2, Siyuan Cui3
1Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China.
Abstract:
Metabolic syndrome (MetS) is closely associated with an increased risk of dementia and cognitive impairment, and a complex interaction of genetic and environmental dietary factors may be implicated. Free fatty acid receptor 4 (Ffar4) may bridge the genetic and dietary aspects of MetS development. However, the role of Ffar4 in MetS-related cognitive dysfunction is unclear. In this study, we found that Ffar4 expression is down-regulated in MetS mice and MetS patients with cognitive impairment. Conventional and microglial conditional knockout of Ffar4 exacerbated high-fat diet (HFD)-induced cognitive dysfunction and anxiety, whereas microglial Ffar4 overexpression improved HFD-induced cognitive dysfunction and anxiety. Mechanistically, we found that microglial Ffar4 regulated microglial activation through type I interferon signaling. Microglial depletion and NF-κB inhibition partially reversed cognitive dysfunction and anxiety in microglia-specific Ffar4 knockout MetS mice. Together, these findings uncover a previously unappreciated role of Ffar4 in negatively regulating the NF-κB-IFN-β signaling and provide an attractive therapeutic target for delaying MetS-associated cognitive decline.
Insights
Free fatty acid receptor 4 (Ffar4) plays a key role in metabolic syndrome (MetS)-related cognitive decline. Targeting Ffar4 in microglia may offer a new therapeutic strategy for preventing dementia associated with MetS.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Immunology
Background:
- Metabolic syndrome (MetS) is linked to dementia and cognitive impairment.
- Free fatty acid receptor 4 (Ffar4) may connect genetic and dietary factors in MetS.
- The specific role of Ffar4 in MetS-associated cognitive dysfunction is not well understood.
Purpose of the Study:
- To investigate the role of Ffar4 in metabolic syndrome-related cognitive dysfunction.
- To elucidate the mechanisms by which Ffar4 influences cognitive function in MetS.
Main Methods:
- Examined Ffar4 expression in MetS mice and patients with cognitive impairment.
- Utilized conventional and microglial conditional knockout and overexpression of Ffar4 in mice.
- Investigated the impact of microglial activation, type I interferon signaling, and NF-κB pathway.
Main Results:
- Ffar4 expression was reduced in MetS mice and patients with cognitive impairment.
- Ffar4 deficiency in microglia worsened high-fat diet-induced cognitive dysfunction and anxiety.
- Ffar4 overexpression in microglia ameliorated these deficits, implicating microglial Ffar4 in regulating NF-κB-IFN-β signaling.
Conclusions:
- Ffar4 negatively regulates microglial activation via the NF-κB-IFN-β pathway.
- Microglial Ffar4 is crucial for mitigating cognitive decline and anxiety in MetS.
- Ffar4 presents a potential therapeutic target for delaying MetS-associated cognitive impairment.
More Related Videos
Related Concept Videos
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Focusing of Light in the Eye
Photoreceptors and Visual Pathways
Prosopagnosia

